Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2007
10/03/2007CN101045931A Thermophilic heat resisting dextran phosphorylase and its prepn process and application
10/03/2007CN101045930A Sisomicin biosynthesizing gene cluster of Micromonospora inyoensis
10/03/2007CN101045929A Raising plant cold endurance and salt tolerance by means of transcription factor gene SNAC2 of rice
10/03/2007CN101045928A Process of cloning new resistance gene of wild rice
10/03/2007CN101045927A Inverted repeats of tomato PG gene promoter and its vector and engineering bacterial strain
10/03/2007CN101045926A Human CLL1 gene and its coded protein and application
10/03/2007CN101045925A Mutual action of CAL and mGluR5 and its effect on mGluR5 expression
10/03/2007CN101045924A Prepn and application of recombinant staphylococcus aureus enterotoxin O
10/03/2007CN101045923A Process of producing interleukin analog
10/03/2007CN101045751A Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof
10/03/2007CN101045748A HIV protease substrate molecular with evolution immune globulin binding molecular, preparation method and application thereof
10/03/2007CN101045742A Dipurification process of recombinant humangranulocyte colony stimulating factor
10/03/2007CN101045167A Method for quantitative determination of in vivo activity of recombination human endothelial chalone
10/03/2007CN101045156A Special target medicine and its use
10/03/2007CN101044836A Method for breeding autoallopolyploid rice
10/03/2007CN100340670C Application of Nano carbon tubes in biology
10/03/2007CN100340668C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
10/03/2007CN100340667C Expression carrier for RNA interference research
10/03/2007CN100340666C Insect-risistant transgenic plants and methods for improving 'delta' -endotoxin activity against target insects
10/03/2007CN100340665C Human p51 genes and gene products thereof
10/03/2007CN100340662C High specific activity phytase gene and its efficient expression
10/03/2007CN100340656C High-efficiency expression in Pichia yeast, fermentation and purification of human gamma-interferon
10/03/2007CN100340574C Tumour tag and its use
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/02/2007US7277798 Methods for extracting similar expression patterns and related biopolymers
10/02/2007US7276652 Seed produced by crossing the variety XW03X with another wheat plant; insect resistance, herbicide resistance, disease resistance
10/02/2007US7276648 Soybean cultivar SN64195
10/02/2007US7276647 Isolated nucleic acid molecules encoding the Dw3 P-glycoprotein of sorghum and methods of modifying growth in transgenic plants therewith
10/02/2007US7276646 Synthetic polynucleotide coding for human lactoferrin, vectors, cell and transgenic plants containing it
10/02/2007US7276643 Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents
10/02/2007US7276605 Method for producing recombinant trypsin
10/02/2007US7276596 Promoter from maize invertase inhibitor gene
10/02/2007US7276595 DNA sequence encoding a retinoic acid regulated protein
10/02/2007US7276594 Nucleic acid-containing complex
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276583 Plant fungicide, pesticides, insecticides; insertion protease detectors; corn
10/02/2007US7276581 Tyrosine kinases; phosphoproteins; antibodies; transgenic mice whose somatic or germ cells express tumors
10/02/2007US7276580 Neurotrophic factors
10/02/2007US7276576 Mammalian ICYP (iodocyanopindolol) receptor and its applications
10/02/2007US7276490 Administering to the cancer cell a pharmaceutical formulation of a nucleic acid encoding and expressing a prostacyclin synthase as an active ingredient and a nucleic acid encoding and expressing a cyclooxygenase-2
10/02/2007US7276488 Vector system
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276375 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
10/02/2007US7276374 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration
10/02/2007US7276373 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
10/02/2007US7276370 Rf2a and rf2b transcription factors
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276363 Produces bioluminescence of Phrixotrhix vivianii (beetles) when expressed in Escherichia; recombinant vectors, host cells
10/02/2007US7276362 Recombinant histidine-tagged inosine monophosphate dehydrogenase polypeptides
10/02/2007US7276361 Modifying a poly(3-hydroxyalkanoate) biosynthetic enzyme by an evolutionary-engineering technique; and expressing the enzyme in a host to synthesize a copolylactone, especially a 3-hydroxybutyric acid-3-hydroxyalkanolic acid copolymer, in a host.
10/02/2007US7276359 Polynucleotide composition, method of preparation, and use thereof
10/02/2007US7276356 Linking a transcriptional control element that binds a DNA-directed RNA polymerase to a DNA sequence that encodes an RNA molecule having a binding site specific for an RNA-directed RNA polymerase of an influenza virus linked to the reverse complement of an mRNA coding sequence of an influenza virus
10/02/2007US7276355 Transcribing and translating heterologous protein using vector coding chaperonin subunits; enhancing in vitro protein synthesis; bioreactors
10/02/2007US7276354 That is used to treat diseases including inflammatory disorders, cancer, esophageal diseases, reproductive diseases, disorders related to aberrant apoptosis regulation, and disorders related to aberrant DNA repair regulation
10/02/2007US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
10/02/2007US7276352 Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor
10/02/2007US7276344 Osteoclastogenesis inhibitory factor protein for treating osteoporosis
10/02/2007US7276339 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
10/02/2007US7276335 Determining the sequence in the targeted RNA that is critical to function, the secondary structure of the region in which the critical site is located, the three-dimensional stature of the targeted RNA, and the sequence of nucleotides and structure flanking the site specific to the critical region
10/02/2007US7276331 Plus end-directed microtubule motor required for chromosome congression
10/02/2007US7276243 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity
10/02/2007US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol.
10/02/2007US7276241 Anticancer agents; administering polypeptide antagonist
10/02/2007US7276240 Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/02/2007US7276234 Introducing a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes, and expressing the foreign DNA in the thymus during differentiation and maturation of the fetal immature T lymphocyte to reconstitute the immune system
10/02/2007US7276233 Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
10/02/2007US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
10/02/2007US7276206 Electrical field stimulation of eukaryotic cells
10/02/2007US7276172 Method for preparing a nanowire crossbar structure and use of a structure prepared by this method
10/02/2007CA2415265C Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk
10/02/2007CA2280156C Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing
10/02/2007CA2262618C Novel boronic acid-containing nucleic acids and their use as diagnostic agents
10/02/2007CA2262018C Nanoparticles having oligonucleotides attached thereto and uses therefor
10/02/2007CA2253956C Vector for introducing a gene into a plant from which a selectable marker gene can be optionally removed
10/02/2007CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/02/2007CA2116543C Methods and reagents for detection of bacteria in cerebrospinal fluid
10/02/2007CA2113432C Production of polyalkanoate
10/02/2007CA1341553C Microinjection procedure for gene transfer in fish
10/02/2007CA1341552C Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof
09/2007
09/30/2007CA2582857A1 Microwave-assisted pcr amplification of dna
09/30/2007CA2582236A1 Tumor models employing green fluorescent protein
09/27/2007WO2007109697A2 The use of protein s fusion for protein solubilization
09/27/2007WO2007109677A2 A novel method of protecting islet cells from apoptosis during the donor harvesting process
09/27/2007WO2007109674A2 Use of eif-5a1 sirna and antisense to treat sepsis or haemorrhagic shock
09/27/2007WO2007109567A1 Anti-tat226 antibodies and immunoconjugates
09/27/2007WO2007109324A2 Potent and selective nav 1.7 sodium channel blockers
09/27/2007WO2007109174A2 Compositions and methods for modulation of mcl-1 expression
09/27/2007WO2007109131A2 Lentiviral vectors that provide improved expression and reduced variegation after transgenesis
09/27/2007WO2007109097A2 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
09/27/2007WO2007109035A2 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
09/27/2007WO2007108955A1 Protein purification
09/27/2007WO2007108841A2 Method for identifying drug-sensitizing antisense dna fragments and use thereof
09/27/2007WO2007108829A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
09/27/2007WO2007108621A1 Sirna for inhibiting nf-kb/rela expression
09/27/2007WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor
09/27/2007WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007WO2007108464A1 Antibody directed against mammal-derived cytoplasmic sialidase
09/27/2007WO2007108434A1 Expression construct for digesting aggregating protein and method of inhibiting the aggregation of aggregating protein
09/27/2007WO2007108393A1 Method for in vitro proliferation of male germline stem cells
09/27/2007WO2007108378A1 Method for formation of signal probe polymer